Latest News

Advocacy

What Does the Government Shutdown Mean for Oncology Pharmacists and Our Patients?

The government shutdown affects oncology pharmacists and our patients in a number of ways. This article provides a summary.

Leadership medical image
Membership HOPA News

A Journey of a Thousand Miles Begins with a Single Step Navigating the Path to a Leadership Position

In this personal reflection from the latest issue of HOPA News, Mary Walters, PharmD, BCOP, and Peter Stuessy, PharmD, BCOP, compare and contrast their journeys into leadership roles - and what advice they would give others on their own leadership paths.

A gathering of HOPA members and advocates on the Capitol steps for Hill Day 2025
Advocacy

Record-Breaking Hill Day Participation Brings HOPA Advocacy, Education to D.C.

HOPA members and staff were hard at work in the nation's capital for HOPA Hill Day on Tuesday, Sept. 30, discussing the hem/onc pharmacy profession and the important issues facing optimized cancer care across the nation.

blue background with white text that reads Patient Education Sheets, Cancer Care Explained
Patient Resources

Leading Cancer Organizations Launch New Patient Education Sheets Website

The new Patient Education Sheets (PES) website is here! Created by NCODA, HOPA, ONS, and ACCC, this updated platform replaces the OCE and IVE websites, offering over 300 trusted, patient-friendly resources to support cancer care.

An image of a lung inside the body
HOPA News Late Breaking News

Late-Breaking HOPA News: Lurbinectedin and Atezolizumab for Extensive-Stage Small Cell Lung Cancer

Ming-Hei Tai, PharmD, BCOP, and Alexis Chapman, PharmD, BCOP, discuss the IMforte trial concerning lurbinectedin and atezolizumab in the treatment of extensive-stage small cell lung cancer.

silver-tone rendering of a molecular structure
Advocacy

Oncology Pharmacists Urge Responsible use of Leucovorin

The drug eucovorin is a well-established, essential component of cancer therapy. A surge in demand for leucovorin could lead to supply shortages.

On an orange background, female healthcare workers are huddled in conversation
Advocacy

HOPA Joins Public Awareness Campaign to Increase Visibility of Pharmacists

"We're Your Pharmacist" educates the public about patient care roles in clinical pharmacy and inspires the next generation of pharmacists.

Young man in a pharmacist coat at work
Advocacy Membership

The Role of the IDS Pharmacy Technician

Members of the HOPA Investigational Drug Services (IDS) special interest group (SIG) have identified specific responsibilities and duties that differentiate the IDS technician role from other advanced and specialized technician roles.

Latina in military fatigues hugging her school-aged daughter
Education Collaborations

HOPA to Present BCOP CEs at AVAHO's Annual Meeting

AVAHO Pre-Conference features The Pre-Conference features three sessions totaling four hours of Board-Certified Oncology Pharmacist (BCOP) continuing education (CE) credits.

Cancer pill medication
Advocacy Membership

HOPA and Coalition to Improve Access to Cancer Care Commend Reintroduction of Cancer Drug Parity Act

HOPA, along with the CIACC, recently voiced its support for the reintroduced Cancer Drug Parity Act, aiming to make oral and self-administered cancer treatments less expensive and more accessible.

School of Pharmacy
Membership HOPA News

No Higher Calling: Reflections on a Career in Higher Education

In this essay from the most recent issue of HOPA NEWs, Amber B. Clemmons, PharmD, BCOP, FHOPA, shares reflections and advice from her career in academia.

HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.